Feasibility study of a mobile device for the prevention of sepsis in patients with solid tumors after chemotherapy and patients with infectiose diseases (COVID-19)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017593

Enrollment

Registered

2019-07-26

Start date

2019-08-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00 Coronavirus, COVID-19, U07.1! C00-C75 U07.1

Interventions

Group 1: 5 days after chemotherapy, patients receive a VitalPatch to record the vital signs. The collected data will be evaluated after return of the product. In addition, the patient is interviewed r

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with solid tumors and planned chemotherapy or patients with infections desease and risk for sepsis.

Exclusion criteria

Exclusion criteria: younger than 18 years older than 99 years Not able to sign informed consent

Design outcomes

Primary

Measure	Time frame
Pilot study on the feasibility and application of a mobile device on two patient collectives with risk for developing a sepsis. There is no primary endpoint because it is a pilot study.	—

Secondary

Measure	Time frame
Sepsis prevention	—

Countries

Germany

Contacts

Public ContactMate Knabe

Uniklinik Frankfurt

mate.knabe@kgu.de06963015357

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026